参考文献/References:
[1]国家卫生健康委员会.胃癌诊疗规范(2018年版)[J].中华消化病与影像杂志(电子版),2019,9(3):118-144.[2]王少明,郑荣寿,张思维,等.2015年中国胃癌流行特征分析[J].中华流行病学杂志,2019,40(12):1517-1521.[3]李星,樊巧玲.胃癌中医辨证与方药应用的文献研究[J].中医杂志,2017,58(8):693-696.[4]张乙,杨琳蔚,李杰,等.基于核心病机的胃癌辨病治疗[J].中华中医药杂志,2020,35(1):300-303.[5]林翔英,林翠丽,田琳,等.脾胃湿热与胃癌前病变炎-癌转化机制的关系简析[J].中医杂志,2021,62(17):1473-1477.[6]吴含秋,沈克平.中医扶正法在胃癌防治中的应用[J].上海中医药大学学报,2022,36(4):92-97.[7]郭群,陈子瑶,邓鑫,等.胃癌从气血论治[J].辽宁中医杂志,2019,46(11):2303-2305.[8]蒲香蓉,冯宇,王茂云,等.人参养荣汤在恶性肿瘤治疗中的运用及研究[J].吉林中医药,2017,37(5):505-508.[9]刘梓燊,杨国旺.基于网络药理学分析“黄芪-白术”治疗肺癌的作用机制[J].中山大学学报(自然科学版),2020,59(5):134-143.[10]郭晨旭,刘静波,赵艳,等.白术抑制胃癌细胞SGC-7901增殖并促进其凋亡[J].中国组织化学与细胞化学杂志,2017,26(5):468-474.[11]孔祥军,岳小强.论“阴虚痰凝毒结”是晚期胃癌的核心病机[J].中医药导报,2017,23(14):56-58.[12]朱广辉,李杰.基于“阳非有余”及“阳常有余”探讨温阳法论治恶性肿瘤[J].辽宁中医药大学学报,2021,23(12):41-44.[13]朱鹏程,罗毅.基于“阳化气,阴成形”及伏阳学说的肿瘤病机刍议[J].南京中医药大学学报,2022,38(3):187-192.[14]窦建卫,杨小娟,李康乐,等.从气机升降探讨胃癌的病机治则[J].辽宁中医杂志,2020,47(2):76-77.[15]张林超.白花蛇舌草多糖对肾癌荷瘤小鼠肿瘤生长及免疫调节作用的影响[J].中成药,2021,43(3):765-769.[16]修朋程,李腾,李雅林,等.泰山山慈菇对小鼠肝癌的治疗作用及相关免疫机制研究[J].医学信息,2018,31(9):8-11.[17]阮祥美,余莹,胡玲.“半枝莲-白花蛇舌草”药对治疗胃癌的网络药理学作用机制分析[J].中华中医药学刊,2020,38(11):176-180.[18]尹慧萍,王兵兵,黄泽月,等.壁虎粗多肽对SH-SY5Y细胞增殖和凋亡的影响[J].中国临床药理学杂志,2021,37(6):681-684.[19]王倩,周改莲,周文良,等.蜂房的研究进展及其质量标志物预测分析[J].中华中医药学刊,2021,39(1):254-258.
相似文献/References:
[1]尹晓华,刘重元,黄 琳,等.胃癌中lncRNAs的研究进展[J].医学信息,2018,31(03):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
YIN Xiao-hua,LIU Zhong-yuan,HUANG Lin,et al.Research Progress of lncRNAs in Gastric Cancer[J].Journal of Medical Information,2018,31(10):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
[2]芮昆昆,章 波,邰小华,等.基质金属蛋白酶2与蛋白磷酸酶2A的癌性抑制因子在胃癌中的研究进展[J].医学信息,2018,31(03):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
RUI Kun-kun,ZHANG Bo,TAI Xiao-hua,et al.The Research Progress of Matrix Metalloproteinase 2 and Cancer Inhibitor of Protein Phosphatase 2A in Gastric Cancer[J].Journal of Medical Information,2018,31(10):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
[3]段 巍.1例晚期胃癌化疗并发嗜血细胞综合征患者的护理[J].医学信息,2018,31(10):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
DUAN Wei.Nursing Care of a Case of Advanced Gastric Carcinoma with Hemophagocytic Syndrome after Chemotherapy[J].Journal of Medical Information,2018,31(10):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
[4]潘理会,李育庄,李春辉.胃癌与高凝血状态关系的研究现状[J].医学信息,2018,31(11):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
PAN Li-hui,LI Yu-zhuang,LI Chun-hui.Research Status of the Relationship between Gastric Carcinoma and Hypercoagulable State[J].Journal of Medical Information,2018,31(10):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
[5]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(10):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[6]林跃韩,许庆文.腹腔镜uncut Roux-en-Y吻合与传统吻合方式的研究进展[J].医学信息,2018,31(22):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
LIN Yue-han,XU Qing-wen.Research Progress of Laparoscopic uncut Roux-en-Y Anastomosis and Traditional Anastomosis[J].Journal of Medical Information,2018,31(10):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
[7]马玉涛,石文娜,李晓林,等.免疫荧光法检测FSHR与GnRHR在胃癌组织中的分布及其共定位研究[J].医学信息,2018,31(23):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
MA Yu-tao,SHI Wen-na,LI Xiao-lin,et al.Study on the Distribution and Co-localization of FSHR and GnRHR in Gastric Cancer Tissues by Immunofluorescence Assay[J].Journal of Medical Information,2018,31(10):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
[8]赵 静.血浆纤维蛋白原和CA724水平在胃癌患者的变化及临床意义[J].医学信息,2018,31(24):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
ZHAO Jing.Changes and Clinical Significance of Plasma Fibrinogen and CA724 Levels in Patients with Gastric Cancer[J].Journal of Medical Information,2018,31(10):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
[9]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息,2018,31(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Journal of Medical Information,2018,31(10):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
[10]牛 悦,白建平,卢建跃.HER-2阳性胃癌的研究进展[J].医学信息,2019,32(01):44.[doi:10.3969/j.issn.1006-1959.2019.01.015]
NIU Yue,BAI Jian-ping,LU Jian-yue.Progress in Research of HER-2 Positive Gastric Cancer[J].Journal of Medical Information,2019,32(10):44.[doi:10.3969/j.issn.1006-1959.2019.01.015]